Introduzca una acción o criptomoneda en el cuadro de búsqueda para obtener un resumen
Cipla Limited
CIPLACipla Limited, together with its subsidiaries, engages in the manufacture, development, sale, and distribution of pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India. Address: Cipla House, Mumbai, India, 400013
Analytics
Precio Objetivo de WallStreet
122 569.7 INRRelación P/E
31.1974Rentabilidad por dividendo
0.78 %Año en curso
Año anterior
Trimestre actual
Último trimestre
Año en curso
Año anterior
Trimestre actual
Último trimestre
Cifras clave CIPLA
Análisis de dividendos CIPLA
Aumento del dividendo durante 5 años
183 %Crecimiento continuo
2 añoRatio de pago medio en 5 años
16 %Tendencia del payout CIPLA
Valoración de la acción CIPLA
Finanzas CIPLA
Realice un seguimiento de las métricas clave de cada acción en un solo lugar y sin complicaciones
Hazte premiumResultados | 2019 | Dinámica |